Conflict of interest
Rebecka
HANSEN, THOMSEN
The trial was sponsored and fully funded by Pharmacosmos A/S, Holbæk, Denmark. The sponsor was involved in the study design, analysis and interpretation of the data, and approval of the final manuscript. Charlotte Holm was the primary investigator of the trial. Lars Lykke Thomsen is employed by Pharmacosmos A/S, as was Veronika Markova Sommer during the trial. Rebecka Hansen was employed by the institution with salary costs funded by Pharmacosmos A/S. Charlotte Holm and Rebecka Hansen have served on advisory boards for Pharmacosmos A/S. Charlotte Holm has received speaker honoraria from Pharmacosmos A/S. The remaining authors have no conflicts of interest to declare.